Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis (Q38309552)

2 September 2017

1 reference

title

Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis (English)

1 reference

2 September 2017

Martin Schlesinger

1

1 reference

PubMed ID

25564456

2 September 2017

Gerd Bendas

series ordinal

2

1 reference

2 September 2017

7 January 2015

1 reference

Cancer and Metastasis Reviews

2 September 2017

1 reference

2 September 2017

34

1 reference

2 September 2017

575-591

1 reference

2 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-014-9545-x

2 September 2017

0 references

cites work

VLA proteins in the integrin family: structures, functions, and their role on leukocytes

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Intracellular signalling controlling integrin activation in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The platelet membrane glycoprotein IIb/IIIa complex. Structure, function, and relationship to adhesive protein receptors in nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Integrin ligands at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Integrin structures and conformational signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Structural basis of integrin regulation and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Aspects of VLA-4 and LFA-1 regulation that may contribute to rolling and firm adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Lutheran/basal cell adhesion molecule accelerates progression of crescentic glomerulonephritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Interaction of monocytoid cells with the mucosal addressin MAdCAM-1 via the integrins VLA-4 and LPAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The integrin VLA-4 supports tethering and rolling in flow on VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

B-cell activation by membrane-bound antigens is facilitated by the interaction of VLA-4 with VCAM-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Developmental regulation of beta1 integrins during angiogenesis in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Regulation of cell adhesion by affinity and conformational unbending of alpha4beta1 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Real-time analysis of very late antigen-4 affinity modulation by shear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Galphas-coupled receptor signaling actively down-regulates alpha4beta1-integrin affinity: a possible mechanism for cell de-adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Nitric oxide/cGMP pathway signaling actively down-regulates α4β1-integrin affinity: an unexpected mechanism for inducing cell de-adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

PI3-kinase γ promotes Rap1a-mediated activation of myeloid cell integrin α4β1, leading to tumor inflammation and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The small GTPase Rap1 is required for Mn(2+)- and antibody-induced LFA-1- and VLA-4-mediated cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Alpha4beta1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the alpha4-cytoplasmic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Talin-1 and kindlin-3 regulate alpha4beta1 integrin-mediated adhesion stabilization, but not G protein-coupled receptor-induced affinity upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The pathogenesis of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

An inducible endothelial cell surface glycoprotein mediates melanoma adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Changes in the levels of integrin and focal adhesion kinase (FAK) in human melanoma cells following 532 nm laser treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Melanoma cell attachment, invasion, and integrin expression is upregulated by tumor necrosis factor alpha and suppressed by alpha melanocyte stimulating hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Constitutive expression of the alpha4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Proinflammatory adhesion molecules facilitate polychlorinated biphenyl-mediated enhancement of brain metastasis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Tumor cell/endothelial cell tight contact upregulates endothelial adhesion molecule expression mediated by NFkappaB: differential role of the shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Shear Stress Increases ICAM-1 and Decreases VCAM-1 and E-selectin Expressions Induced by Tumor Necrosis Factor-α in Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Laminar shear stress acts as a switch to regulate divergent functions of NF-kappaB in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Cell adhesion molecules in the development and progression of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Functional role of alpha 2/beta 1 and alpha 4/beta 1 integrins in leukocyte intercellular adhesion induced through the common beta 1 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Homotypic leukocyte aggregation triggered by a monoclonal antibody specific for a novel epitope expressed by the integrin beta 1 subunit: conversion of nonresponsive cells by transfecting human integrin alpha 4 subunit cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Cell adhesion receptor expression during melanoma progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Identifying site-specific metastasis genes and functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Origins of metastatic traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Metastatic cells will take any help they can get.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The role of vascular cell adhesion molecule-1 in tumor immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Alpha4 integrins and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Paxillin binding to the alpha 4 integrin subunit stimulates LFA-1 (integrin alpha L beta 2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Homeostatic chemokine receptors and organ-specific metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Multiple functions of CXCL12 in a syngeneic model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The origin and function of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

CCL2 (monocyte chemoattractant protein-1) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Recruitment of myeloid cells to the tumor microenvironment supports liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The role of myeloid cells in the promotion of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Neutrophils: key mediators of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Isolation of a tumor factor responsible for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Tumor dormancy in vivo by prevention of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Integrins in angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Roles of integrins in tumor angiogenesis and lymphangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Scl is required for dorsal aorta as well as blood formation in zebrafish embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Biological implications of macrophage infiltration in human tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Myeloid-derived suppressor cells in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Angiogenesis modulates the tumour immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Tumor angiogenesis factors reduce leukocyte adhesion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Monocyte/macrophage infiltration in tumors: modulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

What brings pericytes to tumor vessels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Markers for microscopic imaging of lymphangiogenesis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Very late antigen-1 mediates corneal lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Methods to study lymphatic vessel integrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Central role of the alpha4beta1 integrin in the coordination of avian truncal neural crest cell adhesion, migration, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Cell fusion: biological perspectives and potential for regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Inflammation as a matchmaker: revisiting cell fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The extracellular matrix as a cell survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Apoptosis induced by inhibition of intercellular contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Environment-mediated drug resistance: a major contributor to minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Regulation of eosinophil cell death by adhesion to fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The membrane-proximal KXGFFKR motif of α-integrin mediates chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Novel treatment options for inflammatory bowel disease: targeting alpha 4 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Natalizumab: risk stratification of individual patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Melanoma complicating treatment with natalizumab for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Blocking alpha4-integrins - A small molecule approach to treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

CD14 is a ligand for the integrin α4β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-014-9545-X

10.1007/S10555-014-9545-X

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

25564456

Dimensions Publication ID

2 September 2017

0 references

1 reference

PubMed ID

25564456